Taysha Gene Therapies, Inc.
TSHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $139 | $144 | $88 | $149 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $6 | $9 | $10 |
| Total Curr. Assets | $142 | $150 | $96 | $160 |
| Property Plant & Equip (Net) | $16 | $20 | $26 | $51 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $3 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $4 | $1 |
| Total NC Assets | $18 | $23 | $30 | $54 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $160 | $173 | $126 | $214 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $11 | $22 |
| Short-Term Debt | $2 | $2 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $10 | $18 | $34 | $0 |
| Other Curr. Liab. | $11 | $11 | $17 | $30 |
| Total Curr. Liab. | $26 | $37 | $63 | $52 |
| LT Debt | $61 | $59 | $58 | $63 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $2 | $4 | $4 |
| Total NC Liab. | $63 | $61 | $63 | $67 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $19 | $21 | $22 | $26 |
| Total Liabilities | $89 | $98 | $125 | $119 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$602 | -$513 | -$401 | -$236 |
| AOCI | -$4 | $0 | $0 | $0 |
| Other Equity | $678 | $588 | $402 | $331 |
| Total Equity | $72 | $75 | $1 | $95 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $160 | $173 | $126 | $214 |
| Net Debt | -$76 | -$83 | -$28 | -$86 |